Thanks for the info. Guys in the field in my experience can give you an honest read unlike top execs who need to protect their position. Someone commented about the increases in pricing from SNY but Lantus is and was a blockbuster
Geeesh, thanks I guess. When they first launched Otrexup i watched this company but stayed away. A while ago I thought I read here the sales were moving up. Ugly. Sorry .IF..if they come out with the EPI news I had heard of maybe some can escape. Best of luck and thanks for the responses.
When the sales rock, he will compare Afrezza to larger drugs, when that fails he will try to find people not having success with the drug..or some other garbage. He's a moron and doesn't understand it's the insulin, not the inhaler, that will ultimately create the paradigm shift.
He puts a graph of Tanzeum !! Talks about deceitful
Wonder why he has such a hard on against MNKD, heard it was because he was dismissed when asking questions. Hes been putting out negative stuff for years.
If you saw the results of other Afrezza users and wanted to try it, it would take you 6-10 weeks between appointments and testing. Be realistic. This will take time. Just remember there's no other product delivering normal BG and A1C levels after 8-12 weeks of use ....which is why those results are what you need to fixate on.
Look at the date of this post...March people ..March. Just some loser short
Kevin Sayer, DexCom, Inc. - CEO 
He asked if we're working with the inhaled insulin, with MannKind insulin. Many of the Afrezza patients are CGM users and they're Twitter fanatics. They take pictures of their CGM lines because they're flat, because Afrezza works so quickly that they no longer eat a meal and have this big spike in glucose that goes on for a while before the insulin finally kicks in and then takes them way down because the tail lasts so long. They're in heaven.
Now I don't know what that means for Afrezza sales, but there is a group of people who absolutely love it and use our product and have very good results.
Let's see what happens. If GS comes out reiterating their earlier call...you're correct. There's a chance that GS invited MNKD knowing that they might change their call. Even if we get a hold rating or upgraded price target it will be helpful. One IMPORTANT thing, if we hear nothing today, there's a chance GS changes direction and gets their clients in before starting a short squeeze. How much would GS clients make then???
unfortunately it was most likely a platform to justify their earlier call and reiterate. For once I didnt sell at the top to reload cause wifey's intuition says we go higher . Been in and out since 2010
It's hard to imagine that with a new drug ( and game changer IMO) ,finances looking to be secured regarding current debt, and a pipeline that this share price is so heavily shorted and is not worth more. We can all find plenty of companies with far less ..but they have bigger market caps.
Hunkering down for another punishing day..one day we will win the war!
6 of 20 who know of product are prescribing Afrezza, 4 months out, with all of the competition?? that's a great start!
Then how do you explain Dr Bodes study regarding hypos, The A1C level of patients on Afrezza for 8 or more weeks, Afrezza leaving the system quickly, the reduced blood glucose levels. Restricted FDA guided non inferior studies are not meant to show superiority .At ADCOM the votes were 14-0. 13-1. But more importantly the patients on Afrezza are sharing their results.
Honestly, do you really think Afrezza will fail or are you just doing your shorting thing?
I agree with Al Mann, this will be one of the biggest selling drugs.
You do understand that this is the only monomeric molecule insulin in the world right?
You do understand that it is reducing A1C levels to normal right?
You do understand that it is reducing hypoglycemia right?
You do understand the implications of this right?